LIMS, LIMS Systems and LIMS Software - Laboratory Information Management Systems Software - from LabVantage
 
 
Press Releases
LabVantage in the News 2002
LabVantage Solutions to Enter Into Marketing Agreement with Celadon Laboratories for Advanced Oligonucleotide Primer Design
BOSTON, MA, August 5, 2002 LabVantage Sapphire™ Informatics to be seamlessly integrated with ProbeITyT for cutting-edge oligonucleotide assay design.

LabVantage Solutions, Inc., a leading provider of Discovery Lifecycle LIMS and Enterprise LIMS solutions, and Celadon Laboratories, providers of cutting-edge software for designing and selling oligonucleotide assays for SNP and gene expression analysis, today announced their intention to integrate and co-market their products ProbeITy and LabVantage Sapphire™ for oligonucleotide assay design. This agreement helps streamline the resource intensive assay design process and provides an integrated Discovery Lifecycle framework for research.

ProbeITy determines the optimal structure of primer and probe sets for DNA tests by batch-processing sequence data of genes and suggesting best sequences for creation of tests. For customers who seek to sell oligonuleotide assays, Celadon provides an e-commerce as well as a design function. This product can produce far superior results in a fraction of the time currently spent by researchers. Using ProbeITy, even untrained personnel can perform in minutes the work that can now take an experienced scientist hours or days to perform.

For any given DNA test, there are hundreds of potential designs. However, only a tiny fraction of these produce an accurate and reliable test. To design an optimal test, every one of the hundreds of possibilities needs to be examined. Despite this, existing software acts more like a calculator, examining small portions of molecular sequences individually, and forcing scientists to evaluate each possible design one by one.

"By contrast, Celadon's ProbeITy software is unique because it is the only software that can design a DNA test for any genomic method, chemistry, or instrument simply by inputting data. The software automatically evaluates hundreds of different molecular sequences simultaneously by applying sophisticated algorithms, and leading scientists through the exact sequence of steps needed to design an accurate and reliable test," said Celadon's Chief Executive Officer, Lawrence A. Kessner. "ProbeITy in combination with LabVantage Sapphire™ Informatics is a world-class offering that will help researchers reduce inefficiencies in their time-sensitive processes."

LabVantage Sapphire™ Informatics. Sapphire™ Informatics is a professionally developed and supported Discovery LIMS solution designed to help researchers integrate, automate and manage their business and discovery-related research processes to bring science to market faster. Sapphire™ connects multiple, dissimilar data sources into a logical, scalable, high-performance framework for scientific and business decision-making. Sapphire™ uses a browser-based interface to greatly simplify the education process for end users. Key functional elements of LabVantage Sapphire™ Informatics:

  Works as a scalable information hub with seamless integration to leading analytical solutions.
  Provides assay design and array management with compound management capabilities.
  Reduces manual tasks through process automation.
  Supports regulatory requirements such as 21 CFR Part 11.

About Celadon Laboratories. Celadon Laboratories was founded in 1999 by Raymond Peterson, Ph.D., a population geneticist and former researcher at the National Cancer Institute and National Institutes of Health. In conducting his research, Dr. Peterson recognized the need for more advanced and flexible software for genomics research. Celadon is located at the University of Maryland's technology incubator in College Park, Maryland. Celadon has launched two products, acquired customers including government research laboratories and leading bioscience companies, and has been the recipient of two research and development grants.

Celadon's primary business is developing software products and building customized applications that will dramatically increase genomic scientists' work output and accuracy, and that will provide a platform for the design and sale of oligonucleotides. The Company is developing software for the design of DNA tests and for the collection, management and analysis of DNA test data. Celadon's software will also provide internet connections with major suppliers and manufacturers for the purpose of facilitating electronic commerce. Celadon has developed, and is continuing to create best-of-breed software that integrates with all genetic analysis instruments and all DNA test methods. For more information about Celadon Laboratories, please visit their Web site at www.celadonlabs.com.

About LabVantage Solutions. LabVantage Solutions, a Chatterjee Group company, is the leader in Discovery Lifecycle LIMS and Enterprise LIMS solutions. LabVantage helps customers reach beyond the traditional four walls of the laboratory with solutions that enable information sharing via intranets and extranets. LabVantage has data management and information production software for high throughput screening, genomics, proteomics and traditional manufacturing QA/QC. LabVantage products stand out in the areas of: workflow process automation, open database modeling, and integration of multiple data sources into a single browser interface. The company also offers services that ensure customer success, such as industry and technology consulting, implementation services, application training, and extensive customer support services. For further information about LabVantage Solutions, please visit our web site at www.labvantage.com.

Certain statements contained in this release may be forward-looking statements and are thus prospective. Such forward-looking statements are subject to risks, uncertainties and other factors, which could cause actual results to differ materially from future results expressed or implied by such forward-looking statements.
News & Events
Return to HomepageContact UsHelp On This Site
Search
Press Contact